MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload

MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominen...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular medicine Vol. 41; no. 4; pp. 1909 - 1916
Main Authors Ji, Yue, Qiu, Ming, Shen, Yejiao, Gao, Li, Wang, Yaqing, Sun, Wei, Li, Xinli, Lu, Yan, Kong, Xiangqing
Format Journal Article
LanguageEnglish
Published Greece Spandidos Publications 01.04.2018
Spandidos Publications UK Ltd
D.A. Spandidos
Subjects
Online AccessGet full text

Cover

Loading…
Abstract MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis.
AbstractList MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis.
MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin II-induced differentiation into myofibroblasts, as assessed via α-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin II-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin β3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis.
MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin Il-induced differentiation into myofibroblasts, as assessed via [alpha]-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin Il-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin [beta]3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis.
MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present study, miR-327 levels in fibroblasts were increased in response to cardiac hypertrophy induced by transverse aortic constriction with prominent cardiac fibrosis, particularly when compared with the levels in unstressed cardiomyocytes. In neonatal rat cardiac fibroblasts, induced expression of miR-327 upregulated fibrosis-associated gene expression and activated angiotensin Il-induced differentiation into myofibroblasts, as assessed via [alpha]-smooth muscle actin staining. By contrast, miR-327 knockdown mitigated angiotensin Il-induced differentiation. Cardiac fibroblast proliferation was not affected under either condition. In a mouse model subjected to transverse aortic constriction, miR-327 knockdown through tail-vein injection reduced the development of cardiac fibrosis and ventricular dysfunction. miR-327 was demonstrated to target integrin [beta]3 and diminish the activation of cardiac fibroblasts. Thus, the present study supports the use of miR-327 as a therapeutic target in the reduction of cardiac fibrosis. Abbreviations: BW, body weight; EF, ejection fraction; FBS, fetal bovine serum; FGF, fibroblast growth factor; HW, heart weight; LV, left ventricle; LVPW, left ventricular posterior wall; MAPK, mitogen-activated protein kinase; NRCF, neonatal rat cardiac fibroblasts; TAC, transverse aortic constriction; TL, tibia length Key words: microRNA-327, cardiac hypertrophy, fibrosis, integrin [beta]3
Audience Academic
Author Sun, Wei
Kong, Xiangqing
Ji, Yue
Wang, Yaqing
Shen, Yejiao
Lu, Yan
Gao, Li
Li, Xinli
Qiu, Ming
AuthorAffiliation 1 Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University
2 Department of Cardiology, Graduate Institution of Integrated Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
AuthorAffiliation_xml – name: 1 Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University
– name: 2 Department of Cardiology, Graduate Institution of Integrated Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Author_xml – sequence: 1
  givenname: Yue
  surname: Ji
  fullname: Ji, Yue
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 2
  givenname: Ming
  surname: Qiu
  fullname: Qiu, Ming
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 3
  givenname: Yejiao
  surname: Shen
  fullname: Shen, Yejiao
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 4
  givenname: Li
  surname: Gao
  fullname: Gao, Li
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 5
  givenname: Yaqing
  surname: Wang
  fullname: Wang, Yaqing
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 6
  givenname: Wei
  surname: Sun
  fullname: Sun, Wei
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 7
  givenname: Xinli
  surname: Li
  fullname: Li, Xinli
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 8
  givenname: Yan
  surname: Lu
  fullname: Lu, Yan
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
– sequence: 9
  givenname: Xiangqing
  surname: Kong
  fullname: Kong, Xiangqing
  organization: Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29393356$$D View this record in MEDLINE/PubMed
BookMark eNptkUtr3DAUhUVJaB7tNssiyNpTPSxL2hSG0EcgDwgJdCdkPWY02JYj2YH595VpmqQQ7kKXq3MPR_pOwMEQBwfAGUYrKiT5GnZ9vyIIixWtifgAjjGXuCJ1_fug9BjxinLWHIGTnHcIEVZL8REcEUklpaw5BvfXwaR4d7OuKOEwuc3c6cllaHSyQRu43Y8uTSmO2z3Ug4U-tCnmkGEY7Gyche0ejsnlPCcH45NLXdT2Ezj0usvu8_N5Ch5-fL-_-FVd3f68vFhfVaYWbKpoI7RBrcHSCtpKjxsupCsDwZm3tcWtYYZbaRqOjLZcYEE59cxT712DJD0F3_76jnPbO2vcMCXdqTGFXqe9ijqo_2-GsFWb-KSYwAjLxeD82SDFx9nlSe3inIaSWZU_JaImhNFX1UZ3ToXBx2Jm-pCNWjNKqGhqgYpq9Y6qlHV9MIWaD2X-3kIBkHNy_iU4RmqBqxa4SxChFrhl4cvb577I_9GkfwCAhaJx
CitedBy_id crossref_primary_10_1139_cjpp_2018_0430
crossref_primary_10_2147_DMSO_S248948
crossref_primary_10_3389_fphar_2021_669146
crossref_primary_10_3389_fphar_2023_1092148
crossref_primary_10_3390_genes13081390
Cites_doi 10.1126/scitranslmed.3009008
10.1172/JCI74368
10.1038/nrm3495
10.1158/1078-0432.CCR-12-2736
10.1161/HYPERTENSIONAHA.109.135467
10.1038/nrm1983
10.1073/pnas.0502256102
10.1007/s00018-013-1349-6
10.1152/physrev.00054.2009
10.1093/jrr/rrw069
10.1152/physiolgenomics.00130.2010
10.7150/thno.15007
10.1038/ncb2866
10.1161/01.CIR.103.5.670
10.1038/nature09783
10.1016/S0735-1097(01)01790-9
10.1038/nature07511
10.3390/ijms17050749
10.1161/CIRCHEARTFAILURE.113.000266
10.3892/ijmm.2017.3152
10.3892/ijmm.2015.2105
10.1016/j.ccr.2013.05.004
10.1177/1087057110397359
10.1038/npp.2015.51
10.1002/ejhf.696
10.1038/nrcardio.2012.158
10.1074/mcp.M110.005397
10.1253/jcj.61.91
10.1161/CIRCRESAHA.113.300226
10.1038/nrcardio.2014.125
10.1186/1476-511X-11-55
10.1111/jcmm.12445
10.1016/j.jacc.2013.09.041
10.3892/ijmm.2017.3021
10.1074/jbc.M109.027896
10.1074/jbc.M801296200
10.1517/14728222.2014.1001740
10.1371/journal.pone.0123477
10.1006/meth.2001.1262
10.1038/nrd4140
10.1186/1479-5876-11-222
10.1111/j.1582-4934.2012.01523.x
10.1016/B978-0-12-387786-4.00009-9
10.1016/j.bcp.2016.11.008
10.5603/KP.a2015.0174
10.1161/CIRCULATIONAHA.112.125013
ContentType Journal Article
Copyright COPYRIGHT 2018 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2018
Copyright: © Ji et al. 2018
Copyright_xml – notice: COPYRIGHT 2018 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2018
– notice: Copyright: © Ji et al. 2018
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.3892/ijmm.2018.3428
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList PubMed
ProQuest One Academic Eastern Edition



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-244X
EndPage 1916
ExternalDocumentID A532386480
10_3892_ijmm_2018_3428
29393356
Genre Journal Article
GeographicLocations Beijing China
United States--US
China
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GroupedDBID NPM
---
0R~
2WC
3V.
53G
5GY
7X7
88E
8AO
8FI
8FJ
AAYXX
ABJNI
ABUWG
ACGFO
ACGFS
ADBBV
AEGXH
AENEX
AFKRA
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BPHCQ
BVXVI
C45
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMOBN
F5P
FRP
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
INH
INR
IPNFZ
ITC
M1P
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
RIG
SV3
TEORI
TR2
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c485t-368ac0bc19d83b9f16789e0bc875fd4d1bc5c7d9c670cad7818373f5f3ffe6093
IEDL.DBID BENPR
ISSN 1107-3756
IngestDate Tue Sep 17 21:34:12 EDT 2024
Thu Oct 10 17:51:21 EDT 2024
Thu Feb 22 23:30:07 EST 2024
Wed Jan 10 03:57:39 EST 2024
Fri Aug 23 00:58:51 EDT 2024
Wed Oct 16 01:00:56 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-368ac0bc19d83b9f16789e0bc875fd4d1bc5c7d9c670cad7818373f5f3ffe6093
Notes Contributed equally
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5810199
PMID 29393356
PQID 2012842253
PQPubID 2044958
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5810199
proquest_journals_2012842253
gale_infotracmisc_A532386480
gale_infotracacademiconefile_A532386480
crossref_primary_10_3892_ijmm_2018_3428
pubmed_primary_29393356
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle International journal of molecular medicine
PublicationTitleAlternate Int J Mol Med
PublicationYear 2018
Publisher Spandidos Publications
Spandidos Publications UK Ltd
D.A. Spandidos
Publisher_xml – name: Spandidos Publications
– name: Spandidos Publications UK Ltd
– name: D.A. Spandidos
References 21622897 - Mol Cell Proteomics. 2011 Oct;10(10):M110.005397
25583328 - J Cell Mol Med. 2015 Mar;19(3):608-19
25652534 - Expert Opin Ther Targets. 2015 May;19(5):707-16
28157267 - Eur J Heart Fail. 2017 Feb;19(2):177-191
19901160 - Hypertension. 2010 Jan;55(1):137-43
11849867 - J Am Coll Cardiol. 2002 Feb 20;39(4):672-5
19706597 - J Biol Chem. 2009 Oct 23;284(43):29514-25
22811579 - Circulation. 2012 Aug 14;126(7):800-2
23258295 - Nat Rev Mol Cell Biol. 2013 Jan;14(1):38-48
23344261 - Clin Cancer Res. 2013 Feb 15;19(4):809-20
24898744 - Sci Transl Med. 2014 Jun 4;6(239):239ps3
26365938 - Kardiol Pol. 2016;74(3):280-8
11846609 - Methods. 2001 Dec;25(4):402-8
22260784 - J Cell Mol Med. 2012 Sep;16(9):2150-60
24161319 - J Am Coll Cardiol. 2014 Mar 11;63(9):920-7
27422938 - J Radiat Res. 2017 Jan;58(1):24-32
28977053 - Arq Bras Cardiol. 2017 Nov;109 (5):404-409
25938589 - PLoS One. 2015 May 04;10 (5):e0123477
9070966 - Jpn Circ J. 1997 Feb;61(2):91-118
28949388 - Int J Mol Med. 2017 Nov;40(5):1511-1519
27698941 - Theranostics. 2016 Sep 10;6(12 ):2068-2083
19043405 - Nature. 2008 Dec 18;456(7224):980-4
22449848 - Curr Top Dev Biol. 2012;100:279-317
20959496 - Physiol Genomics. 2011 May 1;43(10):534-42
25695617 - Int J Mol Med. 2015 Apr;35(4):893-900
24449811 - Circ Heart Fail. 2014 Jan;7(1):203-14
20959622 - Physiol Rev. 2010 Oct;90(4):1507-46
25684064 - Neuropsychopharmacology. 2015 Jul;40(8):2015-24
16936699 - Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600
25365073 - J Clin Invest. 2014 Nov;124(11):4673-7
23207731 - Nat Rev Cardiol. 2013 Jan;10(1):15-26
24161931 - Nat Cell Biol. 2013 Nov;15(11):1282-93
25200283 - Nat Rev Cardiol. 2014 Nov;11(11):655-63
23989712 - Circ Res. 2013 Aug 30;113(6):676-89
24053180 - J Transl Med. 2013 Sep 23;11:222
21248840 - Nature. 2011 Jan 20;469(7330):336-42
11156878 - Circulation. 2001 Feb 6;103(5):670-7
23770013 - Cancer Cell. 2013 Jul 8;24(1):45-58
15860581 - Proc Natl Acad Sci U S A. 2005 May 10;102(19):6936-41
27836671 - Biochem Pharmacol. 2017 Jan 1;123:40-51
28627582 - Int J Mol Med. 2017 Aug;40(2):523-530
27213331 - Int J Mol Sci. 2016 May 18;17 (5)
18477567 - J Biol Chem. 2008 Aug 8;283(32):22295-303
22587332 - Lipids Health Dis. 2012 May 15;11:55
24172333 - Nat Rev Drug Discov. 2013 Nov;12(11):847-65
21310850 - J Biomol Screen. 2011 Mar;16(3):313-22
23649149 - Cell Mol Life Sci. 2014 Feb;71(4):549-74
Espinoza-Lewis (key20200713174738_b12-ijmm-41-04-1909) 2012; 100
Huang (key20200713174738_b1-ijmm-41-04-1909) 2015; 19
Dong (key20200713174738_b37-ijmm-41-04-1909) 2009; 284
Gacoń (key20200713174738_b30-ijmm-41-04-1909) 2016; 74
Dirkx (key20200713174738_b24-ijmm-41-04-1909) 2013; 15
Haq (key20200713174738_b42-ijmm-41-04-1909) 2001; 103
Esposito (key20200713174738_b41-ijmm-41-04-1909) 2010; 55
Tao (key20200713174738_b3-ijmm-41-04-1909) 2016; 6
Irelan (key20200713174738_b19-ijmm-41-04-1909) 2011; 16
Kumarswamy (key20200713174738_b11-ijmm-41-04-1909) 2013; 113
Small (key20200713174738_b13-ijmm-41-04-1909) 2011; 469
Heineke (key20200713174738_b22-ijmm-41-04-1909) 2006; 7
Mazalouskas (key20200713174738_b47-ijmm-41-04-1909) 2015; 40
Gao (key20200713174738_b31-ijmm-41-04-1909) 2015; 10
Chien (key20200713174738_b2-ijmm-41-04-1909) 1997; 61
Xing (key20200713174738_b20-ijmm-41-04-1909) 2005; 102
Shi (key20200713174738_b14-ijmm-41-04-1909) 2017; 58
Roncarati (key20200713174738_b26-ijmm-41-04-1909) 2014; 63
Ling (key20200713174738_b29-ijmm-41-04-1909) 2013; 12
Miller (key20200713174738_b46-ijmm-41-04-1909) 2013; 24
Weber (key20200713174738_b40-ijmm-41-04-1909) 2013; 10
Wang (key20200713174738_b35-ijmm-41-04-1909) 2012; 16
Yang (key20200713174738_b7-ijmm-41-04-1909) 2017; 40
Thum (key20200713174738_b9-ijmm-41-04-1909) 2014; 11
Rose (key20200713174738_b44-ijmm-41-04-1909) 2010; 90
Melman (key20200713174738_b25-ijmm-41-04-1909) 2014; 7
Kong (key20200713174738_b38-ijmm-41-04-1909) 2014; 71
Thannickal (key20200713174738_b4-ijmm-41-04-1909) 2014; 124
Wang (key20200713174738_b33-ijmm-41-04-1909) 2013; 11
Tao (key20200713174738_b10-ijmm-41-04-1909) 2015; 19
Maillet (key20200713174738_b23-ijmm-41-04-1909) 2013; 14
Gyöngyösi (key20200713174738_b39-ijmm-41-04-1909) 2017; 19
Lei (key20200713174738_b45-ijmm-41-04-1909) 2011; 10
Lu (key20200713174738_b16-ijmm-41-04-1909) 2017; 123
Olson (key20200713174738_b6-ijmm-41-04-1909) 2014; 6
Livak (key20200713174738_b21-ijmm-41-04-1909) 2001; 25
Bourajjaj (key20200713174738_b15-ijmm-41-04-1909) 2008; 283
Cheng (key20200713174738_b18-ijmm-41-04-1909) 2017; 109
Gao (key20200713174738_b32-ijmm-41-04-1909) 2012; 11
Thum (key20200713174738_b5-ijmm-41-04-1909) 2012; 126
Wu (key20200713174738_b28-ijmm-41-04-1909) 2015; 35
Thum (key20200713174738_b34-ijmm-41-04-1909) 2008; 456
Wang (key20200713174738_b27-ijmm-41-04-1909) 2016; 17
Peterson (key20200713174738_b43-ijmm-41-04-1909) 2002; 39
Ye (key20200713174738_b36-ijmm-41-04-1909) 2011; 43
Zhou (key20200713174738_b8-ijmm-41-04-1909) 2017; 40
Zaid (key20200713174738_b17-ijmm-41-04-1909) 2013; 19
References_xml – volume: 6
  start-page: 239ps3
  year: 2014
  ident: key20200713174738_b6-ijmm-41-04-1909
  article-title: Micrornas as therapeutic targets and biomarkers of cardiovascular disease
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3009008
  contributor:
    fullname: Olson
– volume: 124
  start-page: 4673
  year: 2014
  ident: key20200713174738_b4-ijmm-41-04-1909
  article-title: Fibrosis: Ultimate and proximate causes
  publication-title: J Clin Invest
  doi: 10.1172/JCI74368
  contributor:
    fullname: Thannickal
– volume: 14
  start-page: 38
  year: 2013
  ident: key20200713174738_b23-ijmm-41-04-1909
  article-title: Molecular basis of physiological heart growth: Fundamental concepts and new players
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm3495
  contributor:
    fullname: Maillet
– volume: 19
  start-page: 809
  year: 2013
  ident: key20200713174738_b17-ijmm-41-04-1909
  article-title: Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-2736
  contributor:
    fullname: Zaid
– volume: 55
  start-page: 137
  year: 2010
  ident: key20200713174738_b41-ijmm-41-04-1909
  article-title: Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.109.135467
  contributor:
    fullname: Esposito
– volume: 7
  start-page: 589
  year: 2006
  ident: key20200713174738_b22-ijmm-41-04-1909
  article-title: Regulation of cardiac hypertrophy by intracellular signalling pathways
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm1983
  contributor:
    fullname: Heineke
– volume: 102
  start-page: 6936
  year: 2005
  ident: key20200713174738_b20-ijmm-41-04-1909
  article-title: A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0502256102
  contributor:
    fullname: Xing
– volume: 71
  start-page: 549
  year: 2014
  ident: key20200713174738_b38-ijmm-41-04-1909
  article-title: The pathogenesis of cardiac fibrosis
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-013-1349-6
  contributor:
    fullname: Kong
– volume: 90
  start-page: 1507
  year: 2010
  ident: key20200713174738_b44-ijmm-41-04-1909
  article-title: Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00054.2009
  contributor:
    fullname: Rose
– volume: 58
  start-page: 24
  year: 2017
  ident: key20200713174738_b14-ijmm-41-04-1909
  article-title: Protective effects of seabuckthorn pulp and seed oils against radiation-induced acute intestinal injury
  publication-title: J Radiat Res
  doi: 10.1093/jrr/rrw069
  contributor:
    fullname: Shi
– volume: 43
  start-page: 534
  year: 2011
  ident: key20200713174738_b36-ijmm-41-04-1909
  article-title: The role of microRNA in modulating myocardial ischemia-reperfusion injury
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00130.2010
  contributor:
    fullname: Ye
– volume: 6
  start-page: 2068
  year: 2016
  ident: key20200713174738_b3-ijmm-41-04-1909
  article-title: Crucial role of mir-433 in regulating cardiac fibrosis
  publication-title: Theranostics
  doi: 10.7150/thno.15007
  contributor:
    fullname: Tao
– volume: 15
  start-page: 1282
  year: 2013
  ident: key20200713174738_b24-ijmm-41-04-1909
  article-title: Nfat and mir-25 cooperate to reactivate the transcription factor hand2 in heart failure
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2866
  contributor:
    fullname: Dirkx
– volume: 103
  start-page: 670
  year: 2001
  ident: key20200713174738_b42-ijmm-41-04-1909
  article-title: Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.5.670
  contributor:
    fullname: Haq
– volume: 469
  start-page: 336
  year: 2011
  ident: key20200713174738_b13-ijmm-41-04-1909
  article-title: Pervasive roles of microRNAs in cardiovascular biology
  publication-title: Nature
  doi: 10.1038/nature09783
  contributor:
    fullname: Small
– volume: 39
  start-page: 672
  year: 2002
  ident: key20200713174738_b43-ijmm-41-04-1909
  article-title: Pressure overload hypertrophy and congestive heart failure. Where is the 'Achilles' heel'
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(01)01790-9
  contributor:
    fullname: Peterson
– volume: 456
  start-page: 980
  year: 2008
  ident: key20200713174738_b34-ijmm-41-04-1909
  article-title: MicroRNA-21 contributes to myocardial disease by stimulating map kinase signalling in fibroblasts
  publication-title: Nature
  doi: 10.1038/nature07511
  contributor:
    fullname: Thum
– volume: 109
  start-page: 404
  year: 2017
  ident: key20200713174738_b18-ijmm-41-04-1909
  article-title: Large accumulation of collagen and increased activation of mast cells in hearts of mice with hyperlipidemia
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Cheng
– volume: 17
  start-page: pii: E749
  year: 2016
  ident: key20200713174738_b27-ijmm-41-04-1909
  article-title: Overview of MicroRNAs in cardiac hypertrophy, fibrosis, and apoptosis
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17050749
  contributor:
    fullname: Wang
– volume: 7
  start-page: 203
  year: 2014
  ident: key20200713174738_b25-ijmm-41-04-1909
  article-title: Micrornas in heart failure: Is the picture becoming less mirky
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.113.000266
  contributor:
    fullname: Melman
– volume: 40
  start-page: 1511
  year: 2017
  ident: key20200713174738_b7-ijmm-41-04-1909
  article-title: MicroRNA-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2017.3152
  contributor:
    fullname: Yang
– volume: 35
  start-page: 893
  year: 2015
  ident: key20200713174738_b28-ijmm-41-04-1909
  article-title: Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2015.2105
  contributor:
    fullname: Wu
– volume: 24
  start-page: 45
  year: 2013
  ident: key20200713174738_b46-ijmm-41-04-1909
  article-title: In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.05.004
  contributor:
    fullname: Miller
– volume: 16
  start-page: 313
  year: 2011
  ident: key20200713174738_b19-ijmm-41-04-1909
  article-title: Rapid and quantitative assessment of cell quality, identity, and functionality for cell-based assays using real-time cellular analysis
  publication-title: J Biomol Screen
  doi: 10.1177/1087057110397359
  contributor:
    fullname: Irelan
– volume: 40
  start-page: 2015
  year: 2015
  ident: key20200713174738_b47-ijmm-41-04-1909
  article-title: Integrin β3 haploinsufficiency modulates serotonin transport and antidepressant-sensitive behavior in mice
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.51
  contributor:
    fullname: Mazalouskas
– volume: 19
  start-page: 177
  year: 2017
  ident: key20200713174738_b39-ijmm-41-04-1909
  article-title: Myocardial fibrosis: Biomedical research from bench to bedside
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.696
  contributor:
    fullname: Gyöngyösi
– volume: 10
  start-page: 15
  year: 2013
  ident: key20200713174738_b40-ijmm-41-04-1909
  article-title: Myofibroblast-mediated mechanisms of pathological remodelling of the heart
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2012.158
  contributor:
    fullname: Weber
– volume: 10
  start-page: M110 005397
  year: 2011
  ident: key20200713174738_b45-ijmm-41-04-1909
  article-title: Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells
  publication-title: Mol Cell Proteomics
  doi: 10.1074/mcp.M110.005397
  contributor:
    fullname: Lei
– volume: 61
  start-page: 91
  year: 1997
  ident: key20200713174738_b2-ijmm-41-04-1909
  article-title: Toward molecular strategies for heart disease-past, present, future
  publication-title: Jpn Circ J
  doi: 10.1253/jcj.61.91
  contributor:
    fullname: Chien
– volume: 113
  start-page: 676
  year: 2013
  ident: key20200713174738_b11-ijmm-41-04-1909
  article-title: Non-coding RNAs in cardiac remodeling and heart failure
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.113.300226
  contributor:
    fullname: Kumarswamy
– volume: 11
  start-page: 655
  year: 2014
  ident: key20200713174738_b9-ijmm-41-04-1909
  article-title: Noncoding RNAs and myocardial fibrosis
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2014.125
  contributor:
    fullname: Thum
– volume: 11
  start-page: 55
  year: 2012
  ident: key20200713174738_b32-ijmm-41-04-1909
  article-title: Plasma levels of lipometabolism-related miR-122 and mir-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
  publication-title: Lipids Health Dis
  doi: 10.1186/1476-511X-11-55
  contributor:
    fullname: Gao
– volume: 19
  start-page: 608
  year: 2015
  ident: key20200713174738_b1-ijmm-41-04-1909
  article-title: Attenuation of microrna-16 derepresses the cyclins d1, d2 and e1 to provoke cardiomyocyte hypertrophy
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12445
  contributor:
    fullname: Huang
– volume: 63
  start-page: 920
  year: 2014
  ident: key20200713174738_b26-ijmm-41-04-1909
  article-title: Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.09.041
  contributor:
    fullname: Roncarati
– volume: 40
  start-page: 523
  year: 2017
  ident: key20200713174738_b8-ijmm-41-04-1909
  article-title: miR-27 inhibits the NF-κB signaling pathway by targetingleptin in osteoarthritic chondrocytes
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2017.3021
  contributor:
    fullname: Zhou
– volume: 284
  start-page: 29514
  year: 2009
  ident: key20200713174738_b37-ijmm-41-04-1909
  article-title: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.027896
  contributor:
    fullname: Dong
– volume: 283
  start-page: 22295
  year: 2008
  ident: key20200713174738_b15-ijmm-41-04-1909
  article-title: Nfatc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M801296200
  contributor:
    fullname: Bourajjaj
– volume: 19
  start-page: 707
  year: 2015
  ident: key20200713174738_b10-ijmm-41-04-1909
  article-title: Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.2014.1001740
  contributor:
    fullname: Tao
– volume: 10
  start-page: e0123477
  year: 2015
  ident: key20200713174738_b31-ijmm-41-04-1909
  article-title: Plasma levels of microRNA-145 are associated with severity of coronary artery disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0123477
  contributor:
    fullname: Gao
– volume: 25
  start-page: 402
  year: 2001
  ident: key20200713174738_b21-ijmm-41-04-1909
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔC T method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
  contributor:
    fullname: Livak
– volume: 12
  start-page: 847
  year: 2013
  ident: key20200713174738_b29-ijmm-41-04-1909
  article-title: Micrornas and other non-coding RNAs as targets for anticancer drug development
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd4140
  contributor:
    fullname: Ling
– volume: 11
  start-page: 222
  year: 2013
  ident: key20200713174738_b33-ijmm-41-04-1909
  article-title: Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-11-222
  contributor:
    fullname: Wang
– volume: 16
  start-page: 2150
  year: 2012
  ident: key20200713174738_b35-ijmm-41-04-1909
  article-title: MicroRNA-24 regulates cardiac fibrosis after myocardial infarction
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2012.01523.x
  contributor:
    fullname: Wang
– volume: 100
  start-page: 279
  year: 2012
  ident: key20200713174738_b12-ijmm-41-04-1909
  article-title: MicroRNAs in heart development
  publication-title: Curr Top Dev Biol
  doi: 10.1016/B978-0-12-387786-4.00009-9
  contributor:
    fullname: Espinoza-Lewis
– volume: 123
  start-page: 40
  year: 2017
  ident: key20200713174738_b16-ijmm-41-04-1909
  article-title: Glycine prevents pressure overload induced cardiac hypertrophy mediated by glycine receptor
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2016.11.008
  contributor:
    fullname: Lu
– volume: 74
  start-page: 280
  year: 2016
  ident: key20200713174738_b30-ijmm-41-04-1909
  article-title: Decision-making microRNAs (miR-124, -133a/b, -34a and -134) in patients with occluded target vessel in acute coronary syndrome
  publication-title: Kardiol Pol
  doi: 10.5603/KP.a2015.0174
  contributor:
    fullname: Gacoń
– volume: 126
  start-page: 800
  year: 2012
  ident: key20200713174738_b5-ijmm-41-04-1909
  article-title: Cardiac fibrosis revisited by microRNA therapeutics
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.125013
  contributor:
    fullname: Thum
SSID ssj0025498
Score 2.3696115
Snippet MicroRNA (miRNA/miR) dysregulation has been reported to be fundamental in the development and progression of cardiac hypertrophy and fibrosis. In the present...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1909
SubjectTerms Cardiomyocytes
Cardiomyopathy
Cardiovascular disease
Care and treatment
Coronary vessels
Development and progression
Fibroblasts
Fibrosis
Gene expression
Genetic aspects
Health aspects
Heart diseases
Heart failure
Immunoglobulins
Kinases
Laboratory animals
MicroRNA
Ostomy
Pathology
Rodents
Studies
Surgery
Title MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
URI https://www.ncbi.nlm.nih.gov/pubmed/29393356
https://www.proquest.com/docview/2012842253
https://pubmed.ncbi.nlm.nih.gov/PMC5810199
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELboVkJcEG8WSuUDEqdAEsd2fEILalUh7aqqWmlvlp_qIkhKsj3w75lJvMuGA8fElpzMjD3zjedByHseWHTexMyU6LqJLEdHE8sEpvxYZmtj0KG_XImLm-rbmq-Tw61PYZW7M3E4qH3r0EcOIB1PUpA-9vnuV4Zdo_B2NbXQOCLHJSCFfEaOv5ytLq_2kAvQz5AMV6A3TnIxlm0EJV1-2nz_iZnoRf2RVdiL_UAt_Xs4H2inaeTkgSo6f0IeJxuSLkamPyUPQvOMPFymW_Ln5HqJUXZXq0XGSkm7sdt86KkbpMHRW8Ce3bZrgcLUNJ5GgMxtv-kp4HPgtKf2Nx3iY--7QDHE80dr_Atyc352_fUiS90TMlfVfJsxURuXW1coXzOrYgFqSQV4AQgl-soX1nEnvXJC5s54CZqbSRZ5ZDEGkSv2ksyatgmvCYVNL3Me66B8VeW2tIKDVeOsz41wSoU5-bAjnr4bi2RoABdIZo1k1khmjWSGmUhbjbsHCOhMSgKAdbAOlV5wBjaEqOp8Tk4mM0Hq3XR4xx2ddl2v_8rInLwaGbX_HjBrFGNczImcsHA_AetsT0eaze1Qb5tjETSl3vx_ybfkEf7mGNVzQmbb7j68A4Nla0_JkVzL0ySb8LS6XP4BBGXtAQ
link.rule.ids 230,315,783,787,888,12068,21400,27936,27937,31731,33756,43322,43817,74079,74636
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKKwEXxKtloYAPSJxCk3XsxCe0oFZb6K5QtZV6s_zUblWSkmwP_HtmEu-y4cA1seRkZjwz33gehHzgngXrdEj0GEM3gaUYaGKJwJIfw0ypNQb0Z3Mxvcq_XfPrGHBrY1rlRid2itrVFmPkANJRk4L0sc93vxKcGoW3q3GExgNygK2qAHwdfDmd_7jcQi5AP10xXIbRuIKLvm0jGOnxyermJ1aiZ-UnluMs9h2z9K9y3rFOw8zJHVN09pQ8iT4knfRMf0b2fPWcPJzFW_IXZDHDLLvL-SRh44I2_bR531LbSYOlS8CezbqpgcJUV44GgMx1u2op4HPgtKPmN-3yY-8bTzHF87bW7iW5OjtdfJ0mcXpCYvOSrxMmSm1TYzPpSmZkyMAsSQ8PAKEEl7vMWG4LJ60oUqtdAZabFSzwwELwIpXskOxXdeVfEQqHvkh5KL10eZ6asREcvBprXKqFldKPyMcN8dRd3yRDAbhAMisks0IyKyQzrETaKjw9QECrYxEA7IN9qNSEM_AhRF6mI3I8WAlSb4evN9xR8dS16q-MjMhRz6jt94BbIxnjYkSKAQu3C7DP9vBNtVp2_bY5NkGT8vX_t3xPHk0Xswt1cT7__oY8xl_uM3yOyf66ufdvwXlZm3dRQv8ARo3uCA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSBUXRHkuFPABiVNoso7t-FStSlflsSuEWmlvlp_qVpCUZHvg3zOTeNsNB66JJScz45n5xvMg5D0PLDpvYmamGLqJLMdAE8sElvxYZitjMKC_WIqzi_LLiq9S_lOX0iq3OrFX1L5xGCMHkI6aFKSPHcWUFvH90_z4-neGE6TwpjWN07hPHkhAKSjhcnUHvgAH9WVxBcblJBdDA0cw19Oj9dUvrEkvqo-sxKnsOwbqXzW9Y6fGOZQ7Rmn-mDxK3iSdDew_IPdC_YTsL9J9-VNyvsB8ux_LWcamkrbD3PnQUdfLhaOXgELbTdsArampPY0Anptu3VFA6sBzT-0f2mfK3rSBYrLnz8b4Z-Rifnp-cpalOQqZKyu-yZiojMutK5SvmFWxAAOlAjwArBJ96QvruJNeOSFzZ7wEG84kizyyGIPIFXtO9uqmDi8JheMvcx6roHxZ5nZqBQf_xlmfG-GUChPyYUs8fT20y9AAM5DMGsmskcwayQwrkbYazxEQ0JlUDgD7YEcqPeMMvAlRVvmEHI5Wgvy78estd3Q6f52-k5YJeTEw6vZ7wMFRjHExIXLEwtsF2HF7_KZeX_adtzm2Q1Pq1f-3fEf2QTT1t8_Lr6_JQ_zjIdXnkOxt2pvwBryYjX3bi-dfUoDw1w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-327+regulates+cardiac+hypertrophy+and+fibrosis+induced+by+pressure+overload&rft.jtitle=International+journal+of+molecular+medicine&rft.au=Ji%2C+Yue&rft.au=Qiu%2C+Ming&rft.au=Shen%2C+Yejiao&rft.au=Gao%2C+Li&rft.date=2018-04-01&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892%2Fijmm.2018.3428&rft.externalDBID=n%2Fa&rft.externalDocID=10_3892_ijmm_2018_3428
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1107-3756&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1107-3756&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1107-3756&client=summon